ResearcherMemorial Sloan Kettering Cancer CenterNo recent work listed

Michael Rainone

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5089552203. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma. First author DOI 10.1007/s40291-022-00614-1 ↗
An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice: A Review. Co-author DOI 10.1001/jamaoncol.2019.5963 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zsofia Kinga Stadler · 2 shared papers, 2020–2022 · strength 0.26
- Paper An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical P… DOI 10.1001/jamaoncol.2019.5963 ↗
- Paper Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Panc… DOI 10.1007/s40291-022-00614-1 ↗
Eileen Mary O'Reilly · 2 shared papers, 2020–2022 · strength 0.26
- Paper An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical P… DOI 10.1001/jamaoncol.2019.5963 ↗
- Paper Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Panc… DOI 10.1007/s40291-022-00614-1 ↗
Isha Singh · 1 shared paper, 2020 · strength 0.15
- Paper An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical P… DOI 10.1001/jamaoncol.2019.5963 ↗
Erin E. Salo‐Mullen · 1 shared paper, 2020 · strength 0.15
- Paper An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical P… DOI 10.1001/jamaoncol.2019.5963 ↗
Marinela Capanu · 1 shared paper, 2022 · strength 0.12
- Paper Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Panc… DOI 10.1007/s40291-022-00614-1 ↗
Anna M. Varghese · 1 shared paper, 2022 · strength 0.12
- Paper Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Panc… DOI 10.1007/s40291-022-00614-1 ↗
Binbin Zheng-Lin · 1 shared paper, 2022 · strength 0.12
- Paper Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Panc… DOI 10.1007/s40291-022-00614-1 ↗
Wungki Park · 1 shared paper, 2022 · strength 0.12
- Paper Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Panc… DOI 10.1007/s40291-022-00614-1 ↗
Kenneth H. Yu · 1 shared paper, 2022 · strength 0.12
- Paper Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Panc… DOI 10.1007/s40291-022-00614-1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.